Home › Ichor Partner Scancell Announces Update on SCIB1 Phase 1/2 Clinical...
 

Keywords :   


Ichor Partner Scancell Announces Update on SCIB1 Phase 1/2 Clinical...

2015-06-02 21:34:40| Logistics - Topix.net

Ichor Medical Systems, Inc. is pleased to announce that their partner Scancell Holdings plc presented updated and very encouraging data from the ongoing Phase 1/2 clinical trial of SCIB1, its DNAi 1 2ImmunoBody being developed for the treatment of patients with melanoma, at the American Society of Clinical Oncology meeting in Chicago. The trial is ani 1 2open label, non-randomized study to characterize the safety and tolerability of SCIB1 administeredi 1 2using Ichor's TriGridTM delivery system, as well as provide initial assessment of the ability of SCIB1 to delay ori 1 2prevent disease recurrence in patients with Stage III/IV melanoma.

Tags: partner update phase clinical

Category:Transportation and Logistics

Latest from this category

All news
15.11Eastern North Pacific Tropical Weather Outlook
15.11Atlantic Tropical Weather Outlook
15.11Tropical Storm Sara Graphics
15.11Tropical Storm Sara Public Advisory Number 8A
15.11Tropical Storm Sara Forecast Advisory Number 8
15.11Tropical Storm Sara Graphics
15.11Tropical Storm Sara Forecast Discussion Number 8
15.11Tropical Storm Sara Wind Speed Probabilities Number 8
Transportation and Logistics »
15.11100 SMAX
15.11ANABoeing 747JA809518cm660g
15.1114
15.11
15.11PS3 CECH2500A
15.11
15.11T
15.11adidas
More »